乙胆激活了一种再生性血管扩展机制,该机制对氧化生产敏感
Nelson P Barrera1, Mónica Márquez1, Matías Muñoz-Uribe1
1Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Frontiers in physiology
|June 16, 2025
概括
氧化 (NO) 对于动脉小血管的导向血管扩张至关重要,促进血液流动的分布. 乙胆 (ACh) 触发了NO依赖的再生信号,增强了沿血管的血管扩张.
科学领域:
- 生理学 生理学 生理学
- 心血管研究研究心血管研究
- 内皮细胞功能 内皮细胞功能
背景情况:
- 动脉直径的变化协调了血液流动的分布.
- 内皮通过氧化物 (NO) 和内皮衍生的高极化 (EDH) 等血管扩张信号调节血管度.
- 通过内皮介导血管扩张沿血管的导导已经确立,但NO的作用仍在争论中.
研究的目的:
- 为了研究NO在导向血管扩张中的作用,在小鼠中进行肌肉微循环.
- 阐明在动脉小管中NO依赖信号传播的机制.
主要方法:
- 在体内小鼠的肌肉微循环.
- 使用乙胆 (ACh) 和S-nitroso-N-乙基胺 (SNAP) 的刺激.
- 对NO (L-NAME,L-NA) 和EDH (TEA) 生产的药理封锁.
主要成果:
- ACh诱导的血管扩张沿着血管进行,而SNAP诱导的血管扩张是局部化的.
- NO阻塞降低了休息直径,并抑制了局部和导向的 ACh 反应.
- 在NO阻塞的情况下,ACH诱导的血管扩张的导导增加.
- EDH阻塞抑制了局部血管扩张,但不能抑制导电.
结论:
- ACh激活了一种对NO无敏感的,用于血管扩张的再生传播机制.
- 这种不依赖NO的途径对于微血管功能和血液流量分布至关重要.
- 研究结果澄清了内皮信号在协调血液流动中的整合.
相关概念视频
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Antihypertensive Drugs: Vasodilators
660
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
660
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.6K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.6K
Cholinergic Receptors: Muscarinic
3.4K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
3.4K
Autoregulation of Blood Flow
2.9K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.3K


